| Literature DB >> 31363092 |
Xingchen Yan1, Syuzanna R Harutyunyan2.
Abstract
Conjugate addition of organometallics to carbonyl based Michael acceptors is a widely used method that allows the building of new carbon-carbon (C-C) bonds and the introduction of chirality in a single step. However, conjugate additions to the simplest Michael acceptors, namely unprotected, unsaturated carboxylic acids, are considered to be prohibited by the fact that acid-base reactions overpower any other type of reactivity, including nucleophilic addition. Here we describe a transient protecting group strategy that allows efficient catalytic asymmetric additions of organomagnesium reagents to unprotected α,β-unsaturated carboxylic acids. This unorthodox pathway is achieved by preventing the formation of unreactive carboxylate salts by means of a reactive intermediate, allowing modifications of the carbon chain to proceed unhindered, while the stereochemistry is controlled with a chiral copper catalyst. A wide variety of β-chiral carboxylic acids, obtained with excellent enantioselectivities and yields, can be further transformed into valuable molecules through for instance catalytic decarboxylative cross-coupling reactions.Entities:
Year: 2019 PMID: 31363092 PMCID: PMC6667444 DOI: 10.1038/s41467-019-11345-z
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1State of the art in conjugate additions to unsaturated carboxylic acids and potential value of addition products. a Fundamental problem that prevents the development of conjugate additions to unprotected unsaturated carboxylic acids: mixing of organometallics with carboxylic acids leads to an acid–base reaction, resulting in a carboxylate salt A nearly unreactive toward further reactions. b Overview of transformations of the carboxylic acid functional group leading to its chiral derivatives and new structural motives: carboxylic acids can undergo straightforward functionalization and decarboxylative cross-coupling reactions
Fig. 2Reaction development. a Our approach, based on the use of Lewis acid to promote in situ formation of a transient intermediate B that can undergo conjugate addition of organometallic reagent. b Conjugate addition of EtMgBr to the substrate 1a in the absence of chiral catalyst with varying conditions. c Rationalization of the experimental data in entries 1–7 obtained for conjugate addition of EtMgBr in various conditions
Fig. 31H NMR experiments carried out in CD2Cl2 at −55 °C using substrate 1b, tBuMe2SiOTf and MeMgBr. a Crotonic acid 1b. b Mixture of 1b with 2.2 equiv. of tBuMe2SiOTf. c Isolated pure tBuMe2Si-ester of 1b. d Mixture of 1b with 2.2 equiv. of tBuMe2SiOTf followed by addition of 1.0 equiv. of MeMgBr
Development of the catalytic system for direct asymmetric conjugate addition of EtMgBr to carboxylic acid 1aa
|
| ||||||
|---|---|---|---|---|---|---|
| Entry | L/Cu(I) | LA | Solvent | T [°C] | Conv. [%]b | |
| 1 | – | CH2Cl2 | −78 | 0 | – | |
| 2 | – | CH2Cl2 | 0 | 79d | Rac | |
| 3 | Me3SiOTf | CH2Cl2 | −78 | 74 | 47 | |
| 4 | Me3SiOTf | CH2Cl2 | −78 | 70 | 9 | |
| 5 | Me3SiOTf | CH2Cl2 | −78 | 72 | 47 | |
| 6 | Me3SiOTf | CH2Cl2 | −78 | 87 | 56 | |
| 7 | Me3SiOTf | CH2Cl2 | −78 | 75 | 47 | |
| 8 | Me3SiOTf | THF | −78 | 100 | Rac | |
| 9 | Me3SiOTf | Toluene | −78 | 62 | 80 | |
| 10 | Me3SiOTf | Ether | −78 | 91 | 88 | |
| 11 | Me3SiOTf | −78 | 95 | 92 | ||
| 12e | –78 | 95 | 95 | |||
| 13 | BF3·Et2O | −78 | 19 | 92 | ||
| 14f | BF3·Et2O | −78 | 77 | 97 | ||
| 15f | Me3SiOTf | −78 | 99 | 97 | ||
| 16g | Me3SiOTf | −78 | 100 | 95 | ||
| 17 | Me3SiOTf | 0 | 95 | 88 | ||
| 18 | L4/Cu(I) | Me3SiOTf | tBuOMe | −20 | 97 | 97 |
aReaction conditions: 0.1 M of 1a, 5 mol% of CuBr·SMe2, 6 mol% of L, and 2–3 equiv. of LA followed by the addition of 2–3 equiv. of EtMgBr
bConversion was determined by NMR of reaction crude
cEnantiomeric excess was determined by chiral HPLC after transforming 2a to the corresponding N,N-dimethyl amide derivative
dLess than 20% of 2a formed with many other byroducts
eThe product was obtained as a mixture of silyl ester and free carboxylic acid in the ratio of 62:38, respectively
fThe reaction was performed by first forming Li-carboxylate with nBuLi followed by addition of corresponding LA and EtMgBr
gThe reaction was performed by first forming Na-carboxylate with NaH followed by the additions of Me3SiOTf and EtMgBr
Fig. 4Scope of the substrate and Grignard reagent. aFor details see Supplementary Information. Isolated yields for all the products are shown. The absolute configuration of the products obtained with (R)-L4 or (R,R)-L5 as the ligands are opposite. bReaction conditions: 0.1 M of the substrate in tBuOMe with 5 mol% (R)-L4/CuBr·SMe2 or in tBuOMe/toluene = 1/1 with 10 mol% (R,R)-L5/CuBr·SMe2, 2–3 equiv. of Me3SiOTf and RMgBr. cUsing 5 mol% (R,R)-L5/CuBr·SMe2 as a catalyst in the same condition led to 1a with 93% ee. dUsing 5 mol% (R)-L4/CuBr·SMe2 as a catalyst led to 2e with 57% ee. eThe reaction performed using 10 mol% of (R)-L4/CuBr·SMe2. fThe reaction performed at −40 °C
Fig. 5Synthetic utility of the process. a Ni-catalyzed decarboxylative alkylation and borylation of chiral acid 2k. b Ag-catalyzed decarboxylative bromination of product 3b. c Ag-catalyzed decarboxylative azidation of chiral acid 3h followed by click reaction. d Late-stage functionalization of a RXR antagonist 5a. e Effect of the different procedures on the structure of the final asymmetric conjugate addition of EtMgBr to the carboxylic acid substrate 1l. f Reported synthetic route to a potent 15-lipoxygenase-1-inhibitor 7a. g Synthesis of the derivative 7b in two steps using current methodology. h Synthesis of chiral acid 3c, which is a key intermediate of several natural products. i) HATU, NEt3, NiCl2·glyme, 4,4'-di-t-butyl-2,2'-dipyridyl, ZnEt2, in DMF at RT; ii) N-hydroxyphthalimide, DCC, in CH2Cl2 at RT, 2h, then MgBr2·OEt2, NiCl2·6H2O, 4,4'-dimethoxy-2,2'-bipyridyl, [B2pin2Me]Li, in DMF, THF, at 0 °C 1 h ~ RT 1 h; iii) Ag(Phen)2OTf, dibromoisocyanuric acid, in 1,2-dichloroethane at 60 °C; iv) AgF, K2S2O8, MesSO2N3 in CH3CN, H2O, at 55 °C; v) phenylacetylene, CuTc, in toluene at RT; vi) CuBr·SMe2, (R,R)-L2, Me3SiOTf, MeMgBr, in tBuOMe:Toluene = 1:1, at −20 °C; vii) CuBr·SMe2, (R)-L1, Me3SiOTf, EtMgBr, in tBuOMe at −20 °C; viii) CuBr·SMe2, (R)-L1, nBuLi, Me3SiOTf, EtMgBr, in tBuOMe at −78 °C 2 h ~ RT 16 h; ix) CuBr·SMe2, (R)-L1, Me3SiOTf, nHexMgBr, in tBuOMe at −78 °C; x) SOCl2, DMF (1 drop), in CH2Cl2 at RT, 1 h, then ethyl 6-chloro-1H-indole-2-carboxylate, SnCl4, in CH2Cl2, reflux; xi) CuBr·SMe2, (S,S)-L2, Me3SiOTf, MeMgBr, in tBuOMe:Toluene = 1:1 at −20 °C